Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for save search
Rocky Mountain High Brands, Inc. Recaps Company’s OTC Quarterly Filings For 2023
Published: 2024-02-28 (Crawled : 14:00) - globenewswire.com
RMHB | $0.01 36.36% 450K
|
|
| O: -66.67%
H: 275.0%
C: 275.0%
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea
Published: 2023-11-29 (Crawled : 12:30) - globenewswire.com
VVOS | $2.66 -2.66% 63K
|
Health Technology
|
| O: 171.75%
H: 308.97%
C: 243.67%
fda device treatment clearance therapeutics
Eco Wave Power Chosen by a Major International Energy Company to Conduct Wave Energy Feasibility Studies for the U.S. Coastline
Published: 2024-04-08 (Crawled : 13:00) - prnewswire.com
WAVE | $3.595 -7.58% -8.96% 120K
|
|
| O: 4.94%
H: 207.97%
C: 204.35%
energy company international for
Q BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancer
Published: 2022-07-26 (Crawled : 13:20) - biospace.com/
QBIO | $0.0001 100.0% 500
|
Professional, Scientific, and T...
|
| O: 0.25%
H: 200.0%
C: 200.0%
drug candidate research liver pre-clinical therapy cancer publication
Motorsport Games Announces Debt-for-Equity Exchange with Motorsport Network
Published: 2023-01-30 (Crawled : 21:00) - globenewswire.com
MSGM | $2.49 5.06% 4.82% 120K
|
|
| O: 182.13%
H: 271.97%
C: 188.41%
network games
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Published: 2022-03-21 (Crawled : 13:00) - biospace.com/
NRSN | $1.51 -5.63% -5.96% 270K
|
|
| O: 39.74%
H: 275.23%
C: 185.78%
treatment fda als clearance therapeutics fda clearance primec
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
Published: 2022-12-08 (Crawled : 12:00) - globenewswire.com
PHVS | $18.5 -12.74% -14.59% 69K
|
|
| O: 66.93%
H: 184.96%
C: 173.51%
phvs416 treatment positive study
Foundation for the Future: Sidus Space Looks toward 2024 Launch
Published: 2023-12-28 (Crawled : 14:00) - sidusspace.com
SIDU | $3.71 8.8% 8.09% 84K
|
|
| O: 0.92%
H: 249.21%
C: 160.77%
space
Stellus Private Credit BDC Reports Results for its Third Fiscal Quarter Ended September 30, 2023
Published: 2023-11-09 (Crawled : 20:00) - prnewswire.com
SBNY | $3.3 0.0% 490K
|
Finance
|
| O: 1.85%
H: 236.36%
C: 160.0%
results
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
Published: 2021-03-05 (Crawled : 15:00) - biospace.com/
EYES | $4.14 -0.24% 3.14%
|
Health Technology
|
| O: 60.14%
H: 331.88%
C: 152.84%
fda fda approval retina approval
NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia with its Wearable Neurostimulation Technology
Published: 2021-07-20 (Crawled : 16:00) - biospace.com/
NURO | $3.63 1.68% 1.65% 10K
|
Health Technology
|
| O: 23.62%
H: 197.77%
C: 149.13%
treatment fda device technology fibromyalgia designation
Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment
Published: 2021-12-28 (Crawled : 22:00) - biospace.com/
TSOI | $0.0007 0.0% 13M
|
Manufacturing
|
| O: -1.44%
H: 139.02%
C: 138.54%
covid-19 treatment patent covid cancer
ESSA Pharma Presents Preclinical Data for its First Generation Androgen Receptor N-Terminal Domain Degrader at the 34th EORTC-NCI-AACR Symposium
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
EPIX | $6.67 -5.66% -6.0% 36K
|
Health Technology
|
| O: 19.19%
H: 148.78%
C: 135.12%
pharma preclinical symposium
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
Published: 2022-11-28 (Crawled : 23:00) - biospace.com/
NAOV 4 | $0.75 0.61% 3.5K
|
Health Technology
|
| O: 4.21%
H: 138.89%
C: 134.41%
fda clearance plus painshield
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office
Published: 2023-02-10 (Crawled : 13:20) - prnewswire.com
QBIO | $0.0001 100.0% 500
|
Professional, Scientific, and T...
|
| O: 24.0%
H: 191.94%
C: 132.26%
patent
MicroAlgo Inc. announced plans to establish a practice base to train graduate students for the university
Published: 2023-12-06 (Crawled : 13:00) - prnewswire.com
MLGO | $2.49 5.51% 5.22% 1.2M
|
Professional, Scientific, and T...
|
| O: 70.66%
H: 160.53%
C: 131.96%
train
FT Due Diligence Series – Add-on acquisitions: forging a way for M&A – Lexology
Published: 2023-11-29 (Crawled : 12:00) - spacfeed.com
PACI 4 | $3.77 298.67% 330
|
n/a
|
| O: 8.22%
H: 150.9%
C: 129.46%
series
Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors
Published: 2021-05-05 (Crawled : 13:15) - biospace.com/
NMRD | $0.1053 -28.78% 820K
|
Health Technology
|
| O: 3.62%
H: 143.94%
C: 127.1%
sensor order
Applied UV Announces Acquisition of the Airocide(R) Technology Platform for Airborne Pathogen Reduction
Published: 2021-02-09 (Crawled : 12:00) - biospace.com/
AUVI | $0.695 -2.85% -2.94% 120K
|
Health Technology
|
| O: 73.75%
H: 297.56%
C: 119.0%
acquisition platform
Blue Water Vaccines Announces Exploration of Its Virus-Like Particle (VLP) Platform for Use in Monkeypox Vaccine Candidate
Published: 2022-08-17 (Crawled : 13:00) - biospace.com/
BWV | $0.1802 5.44% 530K
|
|
| O: 37.25%
H: 128.57%
C: 118.29%
water monkeypox candidate vaccine blue platform
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.